Lucía Cordeu

2.0k total citations
23 papers, 1.4k citations indexed

About

Lucía Cordeu is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Lucía Cordeu has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Hematology. Recurrent topics in Lucía Cordeu's work include Epigenetics and DNA Methylation (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Synthesis and biological activity (5 papers). Lucía Cordeu is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Synthesis and biological activity (5 papers). Lucía Cordeu collaborates with scholars based in Spain, United Kingdom and Poland. Lucía Cordeu's co-authors include Leire Gárate, Felipe Prósper, Xabier Agirre, José Román‐Gómez, Antonio Jiménez‐Velasco, Edurne San José‐Eneriz, Anabel Heiniger, António Torres, Marı́a José Calasanz and Amaia Vilas‐Zornoza and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lucía Cordeu

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucía Cordeu Spain	18	970	476	241	240	107	23	1.4k
Vikas Madan Singapore	18	795 0.8×	228 0.5×	140 0.6×	308 1.3×	197 1.8×	33	1.4k
Oksana Nemirovsky Canada	14	653 0.7×	257 0.5×	154 0.6×	72 0.3×	275 2.6×	18	996
Marlene Balys United States	13	775 0.8×	230 0.5×	199 0.8×	259 1.1×	155 1.4×	28	1.1k
Catherine Oppenheimer United States	10	592 0.6×	212 0.4×	93 0.4×	197 0.8×	66 0.6×	15	1.0k
James B. Springer United States	9	297 0.3×	134 0.3×	119 0.5×	97 0.4×	206 1.9×	19	634
Fabiana Fosca Ferrara Italy	12	1.5k 1.5×	105 0.2×	70 0.3×	718 3.0×	165 1.5×	14	1.6k
A M Martelli Italy	10	580 0.6×	91 0.2×	24 0.1×	198 0.8×	191 1.8×	17	785
Hong Chang United States	13	463 0.5×	118 0.2×	121 0.5×	51 0.2×	346 3.2×	18	829
Jelena Anacker Germany	9	343 0.4×	254 0.5×	59 0.2×	45 0.2×	189 1.8×	11	703
Annalisa Lonetti Italy	24	824 0.8×	179 0.4×	26 0.1×	536 2.2×	251 2.3×	57	1.5k

Countries citing papers authored by Lucía Cordeu

Since Specialization

Citations

This map shows the geographic impact of Lucía Cordeu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucía Cordeu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucía Cordeu more than expected).

Fields of papers citing papers by Lucía Cordeu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucía Cordeu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucía Cordeu. The network helps show where Lucía Cordeu may publish in the future.

Co-authorship network of co-authors of Lucía Cordeu

This figure shows the co-authorship network connecting the top 25 collaborators of Lucía Cordeu. A scholar is included among the top collaborators of Lucía Cordeu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucía Cordeu. Lucía Cordeu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agirre, Xabier, Amaia Vilas‐Zornoza, Antonio Jiménez‐Velasco, et al.. (2009). Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia. Cancer Research. 69(10). 4443–4453. 242 indexed citations

José‐Eneriz, Edurne San, Xabier Agirre, Antonio Jiménez‐Velasco, et al.. (2009). Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. European Journal of Cancer. 45(10). 1877–1889. 69 indexed citations

José‐Eneriz, Edurne San, José Román‐Gómez, Antonio Jiménez‐Velasco, et al.. (2009). MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Molecular Cancer. 8(1). 69–69. 97 indexed citations

Agirre, Xabier, Antonio Jiménez‐Velasco, Edurne San José‐Eneriz, et al.. (2008). Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth. Molecular Cancer Research. 6(12). 1830–1840. 173 indexed citations

Martı́n, Vanesa, Xabier Agirre, Antonio Jiménez‐Velasco, et al.. (2008). Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia‐positive acute lymphoblastic leukemia. Cancer Science. 99(9). 1865–1868. 28 indexed citations

José‐Eneriz, Edurne San, José Román‐Gómez, Lucía Cordeu, et al.. (2008). BCR‐ABL1‐induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. British Journal of Haematology. 142(4). 571–582. 31 indexed citations

Montiel‐Duarte, Cristina, Lucía Cordeu, Xabier Agirre, et al.. (2008). Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leukemia Research. 32(5). 709–716. 33 indexed citations

Román‐Gómez, José, Antonio Jiménez‐Velasco, Lucía Cordeu, et al.. (2007). WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. European Journal of Cancer. 43(18). 2736–2746. 65 indexed citations

Román‐Gómez, José, Antonio Jiménez‐Velasco, Xabier Agirre, et al.. (2007). Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leukemia Research. 31(11). 1521–1528. 52 indexed citations

10.

Sanmartín, Carmen, Lucía Cordeu, Elena Cubedo, et al.. (2007). Synthesis and Biological Evaluation of 2,4,6‐Functionalized Derivatives of Pyrido[2,3‐d]pyrimidines as Cytotoxic Agents and Apoptosis Inducers. Archiv der Pharmazie. 341(1). 28–41. 10 indexed citations

11.

Román‐Gómez, José, Antonio Jiménez‐Velasco, Xabier Agirre, et al.. (2007). Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leukemia Research. 32(3). 487–490. 65 indexed citations

12.

Echeverría, Mikel, Lucía Cordeu, Elena Cubedo, et al.. (2006). Synthesis and Biological Evaluation of Heteroaryldiamides and Heteroaryldiamines as Cytotoxic Agents, Apoptosis Inducers and Caspase‐3 Activators. Archiv der Pharmazie. 339(4). 182–192. 7 indexed citations

13.

José‐Eneriz, Edurne San, Xabier Agirre, José Román‐Gómez, et al.. (2006). Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter. British Journal of Haematology. 134(2). 137–144. 25 indexed citations

14.

Cordeu, Lucía, Elena Cubedo, Eva Bandrés, et al.. (2006). Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives. Bioorganic & Medicinal Chemistry. 15(4). 1659–1669. 145 indexed citations

15.

Cubedo, Elena, Lucía Cordeu, Eva Bandrés, et al.. (2006). New symmetrical quinazoline derivatives selectively induce apoptosis in human cancer cells. Cancer Biology & Therapy. 5(7). 850–859. 27 indexed citations

16.

Font, Marı́a, et al.. (2005). Structural characteristics of novel symmetrical diaryl derivatives with nitrogenated functions. Requirements for cytotoxic activity. Bioorganic & Medicinal Chemistry. 14(6). 1942–1948. 10 indexed citations

17.

Bandrés, Eva, Esther Andion, Victoria Catalán, et al.. (2005). Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. Journal of Neuro-Oncology. 73(3). 189–198. 9 indexed citations

18.

Sanmartín, Carmen, Mikel Echeverría, Lucía Cordeu, et al.. (2005). Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers. Bioorganic & Medicinal Chemistry. 13(6). 2031–2044. 41 indexed citations

19.

Agirre, Xabier, José Román‐Gómez, Iria Vázquez, et al.. (2005). Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer. 118(8). 1945–1953. 76 indexed citations

20.

Bandrés, Eva, Victoria Catalán, Iosu Sola, et al.. (2004). Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma. Oncology Reports. 12(2). 287–92. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact